US2011137056A1PendingUtilityA1
Chemical Process For Preparation Of Intermediates
Est. expiryAug 5, 2026(~0 yrs left)· nominal 20-yr term from priority
C07C 233/58C07C 2601/02C07C 29/143C07C 67/343C07C 33/46C07B 2200/07C07D 301/26C07C 231/02C07D 303/08C07C 67/26C07C 69/753
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to compounds useful as pharmaceutical intermediates, to processes for preparing the intermediates, to intermediates used in the processes, and to the use of the intermediates in the preparation of pharmaceuticals. In particular, the present invention concerns enantiomerically pure trans-cyclopropane carboxylic acid derivatives, processes for preparing the carboxylic acid derivatives and their use in preparing pharmaceuticals.
Claims
exact text as granted — not AI-modified1 . A process for preparing a compound of formula IV
wherein R is an alkyl group, comprising:
treating a compound of formula III
with a compound of formula 3
wherein R 1 and R 2 are, independently, alkyl.
2 . A process according to claim 1 wherein the compound of formula 3 is triethyl phosphonoacetate.
3 . A process according to claim 1 wherein R, R 1 , and R 2 are, independently, selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, and tert-butyl.
4 . A process according to claim 1 further comprising converting the compound of formula IV to a compound of formula VII
5 . A process according to claim 4 wherein the compound of formula IV is treated with ammonia in the presence of a suitable base.
6 . A process according to claim 1 further comprising preparing the compound of formula III by treating a compound of formula II
with a base.
7 . A process for preparing a compound of formula IV
wherein R is an alkyl group, comprising:
a) reducing a compound of formula I
to give a compound of formula II
b) treating the compound of formula II with a base to give a compound of formula III
c) treating the compound of formula III with a compound of formula 3
wherein R 1 and R 2 are, independently, selected from alkyl.
8 . A process according to claim 7 wherein the compound of formula III is triethyl phosphonoacetate.
9 . A process according to claim 7 wherein R, R 1 and R 2 are, independently, selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, and tert-butyl.
10 . A process according to claim 7 further comprising converting the compound of formula IV to a compound of formula VII
11 . A process according to claim 10 wherein the compound of formula IV is treated with ammonia in the presence of a suitable base.
12 . A process for preparing a compound of formula IV
wherein R is an alkyl group, comprising:
a) treating the compound of formula II
with a base; and
b) treating the product of a) with a compound of formula 3
wherein R 1 and R 2 are, independently, selected from alkyl.
13 . A process according to claim 12 wherein the base is sodium hydroxide.
14 . A process according to claim 12 wherein R, R 1 and R 2 are, independently, selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, and tert-butyl.
15 . A process according to claim 12 wherein the compound of formula 3 is triethyl phosphonoacetate.
16 . A process according to claim 12 further comprising converting the compound of formula IV to a compound of formula VII
17 . A process according to claim 16 wherein the compound of formula IV is treated with ammonia in the presence of a suitable base.
18 . A process for preparing a compound of formula VII
comprising treating the compound of formula IV
with ammonia in the presence of a suitable base.
19 . A process according to claim 18 wherein the base is sodium methoxide.
20 . A process according to claim 18 wherein the base is potassium methoxide.
21 . A compound of formula II
or formula III
or formula VIIJoin the waitlist — get patent alerts
Track US2011137056A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.